chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shortness of breath; chest pain; nausea; fatigue; arm pain at injection site; This is a spontaneous report received from contactable reporter(s) (Other HCP) via COVID-19 Adverse Event Self-Reporting Solution (COVAES).  A 13 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 06Nov2021 10:00 (Lot number: FF8841) at the age of 13 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Seizure" (unspecified if ongoing). Concomitant medication(s) included: DEPAKOTE; STRATTERA; HYDROXYZINE; HYDROXYZINE HCL (ongoing); DIVALPROEX SODIUM (ongoing); SINGULAIR (ongoing); ATOMOXETINE HCL (ongoing). Past drug history included: Amoxicillin, reaction(s): "drug allergy". Vaccination history included: Bnt162b2 (Dose 1, single, Batch/Lot number: FF8841, via intramuscular route of administration), administration date: 16Oct2021, when the patient was 13 years old, for COVID-19 immunization. The following information was reported: DYSPNOEA (non-serious) with onset 08Nov2021, outcome "recovering", described as "shortness of breath"; CHEST PAIN (non-serious) with onset 08Nov2021, outcome "recovering", described as "chest pain"; NAUSEA (non-serious) with onset 08Nov2021, outcome "recovering", described as "nausea"; FATIGUE (non-serious) with onset 08Nov2021, outcome "recovering", described as "fatigue"; VACCINATION SITE PAIN (non-serious) with onset 08Nov2021, outcome "recovering", described as "arm pain at injection site". The events "shortness of breath", "chest pain", "nausea", "fatigue" and "arm pain at injection site" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dyspnoea, chest pain, nausea, fatigue, vaccination site pain.  Additional information: The patient was not received other vaccine in four weeks. The patient received other medication in two weeks were DEPAKOTE, STRATTERA, HYDROXYZINE. Prior vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not tested for COVID-19. The vaccine was administered at pharmacy or drug store. The vaccine was not administered at private facility. The patient underwent lab test and procedure on 08Nov2021 which includes red blood cell sedimentation rate (sed rate): 0 (Normal), C-reactive protein (CRP): unknown result, Troponin T: less than 7 (Normal), Electrocardiogram (EKG): Normal. The reporter stated that the event was related to the BNT162B2. The reporter stated, the patient normally sees doctor. The reporter stated, the patient mother wanted him to continue to see doctor for any further follow up.  No follow-up attempts are possible. No further information is expected.
Headache, body aches, chills started approximately 6 hours post vaccine.  Treated only with Advil and Tylenol .  Symptoms, including tiredness,  were prominent for first 24 hours; less but still apparent for next 24 hours ( same treatment used).  Symptoms resolved by 3 days post vaccine.
Swollen arm, bump at injection site, cold feeling, brain fog, no energy for two days. Took Tylenol
Rash at and around injection site; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 26 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE RASH (non-serious), outcome "unknown", described as "Rash at and around injection site".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick feeling stomach), DIZZINESS (really dizzy had to lay down), HEADACHE (light headache) and DIZZINESS (lightheaded) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), LORATADINE (CLARITIN [LORATADINE]) and VITAMINS NOS for an unknown indication. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced ILLNESS (sick feeling stomach), DIZZINESS (really dizzy had to lay down), HEADACHE (light headache) and DIZZINESS (lightheaded). The patient was treated with IBUPROFEN (ADVIL 12HOUR) ongoing since an unknown date at an unspecified dose and frequency. On 28-Jan-2021, ILLNESS (sick feeling stomach), DIZZINESS (really dizzy had to lay down), HEADACHE (light headache) and DIZZINESS (lightheaded) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. corrective treatment included 2 IBUPROFEN and drank water. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Event outcome updated.
No adverse event; received 2 same doses of the GARDASIL 9 vaccine back-to-back.; This spontaneous report was received from an consumer and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 16-JUN-2023, the patient was vaccinated with two doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 1 dose, lot #W026977, expiration date: 04-JAN-2025, administered for prophylaxis (strength, and route of administration were not provided). The patient had received 2 same doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) vaccine back-to-back (Accidental overdose). Patient had not experienced any side effects. No additional adverse event were reported.
3 to 4 episodes of orocular migraines/ocular migraines; Vision was impaired during the Monday and Tuesday events while on computer for work; w zig zag lines.  Mon June 1 and Tuesday June 2 same thing but with colors redbone, orange bars; This is a spontaneous report from a contactable consumer (patient) reported for herself that. A 63-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm on 03May2021 17:45 (age at vaccination: 63-year-old) (Batch/Lot Number: Ew0179) as single dose for COVID-19 immunization. The patient past medical history included autoimmune thyroiditis from an unknown date and unknown if ongoing, hypertension from an unknown date and unknown if ongoing, obesity from an unknown date and unknown if ongoing. Concomitant medications included atenolol taken for an unspecified indication, irbesartan taken for an unspecified indication, levothyroxine taken for an unspecified indication. The allergy includes valdecoxib, verapamil and nifedipine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 28May2021 at 11:00 pm, The patient experienced 3 to 4 episodes of oracular migraines starting Friday and again Saturday 29May2021 w zig zag lines. On Monday 01Jun2021 and Tuesday 28Jun2021 same thing but with colors redbone, orange bars. Each lasted about 20 minutes. Vision was impaired during the Monday and Tuesday events while on computer for work. she has never experienced ocular migraines until this time. The events result in Doctor or other healthcare professional office/clinic visit. The patient not received treatment. The events outcome was recovered on unknown date in 2021.  No follow-up attempts are possible. No further information was expected.
Fever; Muscle pain; Joint pain; I have a rash behind my ear, rash on my chin, rash on my face and a rash on my chest; Extremely tired; really irritating me; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single, lot/batch number, expiry date and route of administration unspecified), for covid-19 Immunization; Bnt162b2 (dose 2, single, lot/batch number, expiry date and route of administration unspecified), for covid-19 Immunization.  The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "Fever"; MYALGIA (non-serious), outcome "unknown", described as "Muscle pain"; ARTHRALGIA (non-serious), outcome "unknown", described as "Joint pain"; RASH (non-serious), outcome "unknown", described as "I have a rash behind my ear, rash on my chin, rash on my face and a rash on my chest"; FATIGUE (non-serious), outcome "unknown", described as "Extremely tired"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "really irritating me".  Additional information: Patient received bnt162b2 (COMIRNATY) via unspecified route of administration. It was reported that the patient was having side effects because of the booster shot of Pfizer. It was reported that the patient had an allergic reaction with this booster shot." Reportedly the patient had a fever, muscle pain, joint pain, the patient also had rash behind patient ear, chin, face and on a chest. It was reported that the patient was extremely tired and that was basically it." It was reported that the patient is Probation officer of law enforcement at (withheld). When probed for consent to follow up: the reporter stated, yes that was fine, but patient just want to know when these side effects go away because this was really irritating for patient." It was further stated that so there was really nothing you can do for the self call. We (further clarification unknown) have side effects so there was literally nothing you can provide patient. What patient can do to get rid of it." Further probing could not be initiated as consumer hung up abruptly. Hence, product details (LOT#, expiration date, NDC#, UPC#), purchase details and other details were unknown and limited information was available over the call. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This is a spontaneous report from a contactable nurse received via a sales representative. A female patient of an unspecified age and ethnicity received the first dose of TRUMENBA, intramuscular at 0.5 ml single and the first dose of MENVEO, intramuscular at 1 DF single, both on the same unspecified date. The patient medical history and concomitant medications were not reported. The patient experienced stiff neck that night on same day vaccines were given. The patient recovered completely. Follow-up (17-AUG-2016) Follow-up attempts are completed. No further information is expected.
Positive COVID PCR 7/16/20. Fully vaccinated 3/6/2021. Positive COVID PCR 4/24/21.
cough 7 days /p immun.- increased fever 1 degree, day /p (T 103.9)- respiratory difficulty-Weds 23Jan had convulsion- took to PRMH, DX:/w pneumonia & otitis media- put on Ceclor, N & V started 3Feb91
pain at the injection site; swelling at the injection site; low grade fever; chills; constipation; abdominal pain; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th February 2022, the patient received the 1st dose of Shingrix. On 26th February 2022, 1 days after receiving Shingrix, the patient experienced injection site pain, injection site swelling, low grade fever, chills, constipation and abdominal pain. On an unknown date, the outcome of the injection site pain, injection site swelling, low grade fever and chills were recovered/resolved and the outcome of the constipation was not recovered/not resolved and the outcome of the abdominal pain was unknown.   It was unknown if the reporter considered the injection site pain, injection site swelling, low grade fever, chills, constipation and abdominal pain to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix vaccine in left arm. On the next morning, she woke up with pain and swelling at injection site, a few hours later she reported low grade fever and chills. The patient also experienced constipation (not resolved) and abdominal pain.  The patient was referred to HCP (health care professional).  The reporter did not consent to follow-up.
Patient suffered from lightheaded episode, dizziness, and little vomiting  few minutes after the injection.   After checking patient's blood pressure, providing hydration and being check by first res ponders , she was OK and drove back home.
Severe diaper rash-ulcers. Sick, tired, wouldn't walk well for 12 days-no diarrhea. No other viral symptoms.
Teeth grinding , TMJ that lead to cracking a tooth, it feels like my jaw is stuck in a clench and the pain and force of pressure is radiating all over causing unbearable jaw pain , chronic headaches, and brain fog. Then I started feeling like my body became very heavy, like someone is squeezing my arms and tingling and numbness in my arms and legs and like someone is sitting on my chest. I have gone to primary doctor, EMT, chiropractor, pain management doctor , acupuncturist, ,massage therapist and dentist and nothing helps at all. Mouthguard, massage and adjustments alleviate the pain slightly but my jaw goes right back to a clench and sometimes it feels like I am going to suck down my tongue. Following up with TMJ specialist November 6.
Patient presented to ED and was subsequently hospitalized within 6 weeks of receiving COVID vaccination. ED to hospital admission occurred on 3/27/21, and patient also presented to ED on 3/31/21.
pt says that she has a tremendous amount of body and muscles aches with extreme fatigue.  She already had numbness and tingling throughout her entire body (including lips and face) but became much more severe in April.  In the last couple of weeks she has developed rashes on various parts of her body.  Pt had appt w/ PCP.  She had blood work that was negative and was referred to a Rheumatologist.  On 6/3/21 she went to another doctor. She had more blood work. Pt is waiting on results.  She also went to see another doctor.  She had more blood work and waiting on these results.  She has an appt Neurologist.  She also had swelling with her gums for a couple of days. She has a very foggy feeling like she is spaced out.  She feels like her vision has been impaired.  She still feels bad most days saying the her symptoms come and go and she has felt this way since taking the vaccine.  She has headache that come and go for the last couple of weeks.
pt recv vax & w/in 3 to 6 months of vax devel diabetes;
Information has been received from a physician concerning a female who was vaccinated with PNEUMOVAX (lot # not provided).  Secondary suspect therapy included influenza virus vaccine (unspecified) in the same arm on the same day.  After receiving the vaccination, the patient experienced swelling and redness in the area of the injection.  The patient sought medical attention.  The physician reported that she thought the patient might have cellulitis and did not believe the adverse events were vaccine-related.  At the time of the report, the outcome of the patient was unknown.  Additional information is not expected.
Patient complains of headache, feeling lightheaded, and general ache. Symptoms similar to flu-like symptoms. Patient also complains of falling in and out of sleep.
Pt. complained that he wasn't feeling well at approximately 12 pm 8-26-2009. He started shaking and was dizzy. He stated that his right arm, chest and the right side of his head hurt, along with a severe headache. He had a temperature of 101.6 f. He was feeling very tired and went to bed after I gave him some ibuprofen. His arm was red and swollen. He also said that his stomache hurt. He was very cold and took a long time to warm up with several blankets and it was 95 degrees outside. It took about 4 hours before his fever stopped. I woke him up from his nap to make sure that he was ok and gave him more medicine. Later, when he complained that his arm and whole right side still hurt badly, is when I realized that it was related to his having the dtap shot the day before. I read the CDC sheet that was given to me to determine what to do. I felt that he was in the moderate range, but on the verge of severe problems according to the risks listed. I waited and the next day his problems were the same but less severe. It has now been 4 days and he is still sore, but the other symptoms stopped 2-3 days after the shot.
This case was reported by a physician via call center representative and described the occurrence of lymphadenopathy in a patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced lymphadenopathy. On an unknown date, the outcome of the lymphadenopathy was unknown. It was unknown if the reporter considered the lymphadenopathy to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The reported stated that the patient experienced left sided supraclavicular lymphadenopathy. The reporter refused to provide any additional information regarding this event.
missed period to todays date (82 days). Still currently no period. Feel irritable and blown
This spontaneous report has been received from a register nurse, via company representative, concerning a 14 year old female patient. The patient's concurrent conditions, historical conditions, previous drug reactions, or allergies and concomitant medication were not reported. On an unknown date, the patient was vaccinated with second dose of GARDASIL 9 (route and anatomical location, lot and expiration date were not reported) as prophylaxis. On an unknown date, she developed a "red ring" around the injection site, and she recovered from the event, "a year later". No additional information was provided. The causal relationship between the event injection site erythema and GARDASIL 9 was not reported.
She states she got "deathly ill" notes that it was worse than her bowel obstructions.  She had body aches, fatigue, slight fever, vomiting.  States her stomach was "on fire".  Her husband had to go to the store to by gas-x and that did not help.  After several hours like this she stated she had to use her fentanyl that she only uses for obstructions and that was the only thing that gave her any relief.    Patient states she is a nurse and feels like this should be reported.
Son had a fever running about 99.9 beginning on Monday night (June 7) and Wednesday he woke up, had his formula bottle of approx. 4 ounces and vomited it up entirely...he repeated this behavior at 6:15 am following a bottle and after every feeding thereafter. He also had diarrhea several times throughout the day. Father called doctor office and was told to give child pedialyte and 1/2 pedialyte; 1/2 formula bottles after that if he could tolerate it. Child refused to drink pedialyte and kept vomiting up his formula.
patient stated that her arm got very hot and warm to touch and red spots at the sight of the injection and the redness relocated to the lower part of her arm under the injection, there is bruise-like blemishing with small red dots
other zoster-related conditions; shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a currently 71-year-old patient (pt) of unknown gender. The pt's concurrent conditions, medical history and concomitant medications were not reported. On or about 07-JUL-2016, the pt was administered the zoster vaccine live (ZOSTAVAX) vaccine (lot #, expiration date, dosage, route of administration and anatomical location were not provided) for the long-term prevention of shingles and zoster-related conditions, by a pharmacist at the pharmacy. Subsequently, on an unknown date, the pt was treated by a physician at the clinic for the following injuries resulting from the pt's use of zoster vaccine live (ZOSTAVAX): shingles and other zoster-related conditions. The outcome of the shingles and other zoster- related conditions was not reported. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
Deep Vein Thrombosis resulting in massive blood clotting in lung - pulmonary embolism
9MAY96 412Pm mom returned to office d/t pt devel hives all over body, size of red raised areas varied;no resp distress noted;started new formula p/vax;hives-etiology unk
blood glucose high; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (blood glucose high) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02A621A and 030M20A.) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included LINAGLIPTIN (TRADJENTA), INSULIN DETEMIR (LEVEMIR), CHLORTHALIDONE, CLOPIDOGREL BISULFATE (PLAVIX) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (blood glucose high). At the time of the report, BLOOD GLUCOSE INCREASED (blood glucose high) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Dec-2020, Glycosylated haemoglobin: 6.5 (High) High. On 08-Apr-2021, Glycosylated haemoglobin: 8.2 (High) High.         Patient had a readjustment in insulin pump settings and Issues lasted around 6 weeks after vaccination was noted.   This case was linked to MOD-2021-276362 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up received on 4-Aug-2021 contains significant information. Event outcome changed to recovered/resolved
Itching; short of breath at times; diarrhea; This is a spontaneous report from a contactable male consumer (patient) received from Pfizer sponsored program. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 28Jan2021 as single dose for covid-19 immunisation. Medical history included stent placement from an unknown date and unknown if ongoing (Had a stent put in on December). Concomitant medication included metformin clopidogrel bisulfate. The patient experienced itching, short of breath at times and diarrhea. The action taken in response to the event for BNT162B2 was not applicable. The outcome of events was unknown.  Information about lot/batch number has been requested.
Mild headache, diarrhea, nausea, vomiting, sore arm
Patient was given an expired dose of the Pfizer vaccine. Vaccine was reconstituted 12/22/2021 @ 2:41am and vaccine was given the next day past the 6 hour window for the reconstituted vial. Patient informed of staff error and has absolutely no side effects or adverse reaction to dose given. Per doctor, no follow up needed however patient can return after one week for re booster.